ICAM-1 was the only marker which early-stage AD control had significantly more than depression control, showing that ICAM-1 level in the DLPFC is increased with age, which is also consistently with the previous finding in the orbitofrontal cortex [83]. The gene discussed is ICAM1; the disease is depressive symptom measurement.